Tango Therapeutics, Inc. · NASDAQ:TNGX
Third Rock Ventures IV, L.P. reported a 4.74% stake in Tango Therapeutics, Inc. (Schedule 13D/A)
Event Feb 6, 2026 · Filed Feb 10, 2026
Third Rock Ventures IV, L.P. reported a 4.74% stake in Tango Therapeutics, Inc., 6,374,574 shares, with active intent on Feb 6, 2026. Filed Feb 10, 2026 (Schedule 13D/A).
- Stake
- 4.74%
- Shares
- 6,374,574
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Third Rock Ventures IV, L.P. | 4.74% | 6,374,574 |
| Third Rock Ventures GP IV, L.P. | 4.74% | 6,374,574 |
| TRV GP IV, LLC | 4.74% | 6,374,574 |
Source
Related
- Tango Therapeutics, Inc.
- Third Rock Ventures IV, L.P.
- Tango Therapeutics, Inc. shareholders
- Schedule 13D/A · Third Rock Ventures IV, L.P. · Nov 21, 2025
- Schedule 13D/A · Third Rock Ventures IV, L.P. · Nov 14, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026